logo

Correvio Pharma Corp. (CORV)



Trade CORV now with
  Date
  Headline
12/24/2019 8:01:35 AM Correvio Receives Complete Response Letter From FDA For Brinavess
12/11/2019 8:09:26 AM Correvio Pharma Plans To Explore Strategic Alternatives
12/11/2019 8:02:47 AM Correvio Plans To Explore Strategic Options
12/10/2019 7:07:33 AM Correvio Announces FDA Advisory Committee Meeting To Discuss Brinavess For Recent Onset Atrial Fibrillation
11/14/2019 7:19:53 AM Correvio Q3 Net Loss $10.8 Mln Vs Net Loss $7.1 Mln Last Year
11/4/2019 7:15:00 AM Correvio Announces FDA Advisory Committee Meeting To Review Brinavess For Recent Onset Atrial Fibrillation
9/3/2019 8:03:28 AM Correvio Announces Presentation Of Brinavess® Spectrum Data
8/14/2019 7:13:30 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Net Income $5.4 Mln Or $0.16/Shr Prior Year
8/14/2019 7:12:03 AM Correvio Q2 Net Loss $10.5 Mln Or $0.26/Shr Vs Income Of $5.4 Mln Or $0.16/Shr Last Year
8/7/2019 9:28:54 AM Correvio Closes Public Offering Of 9.20 Mln Common Shares
8/2/2019 9:16:24 AM Correvio Pharma Prices Underwritten Public Offering Of 8 Mln Shares At US$1.50/shr
7/25/2019 7:19:22 AM Correvio Pharma Says US FDA Accepts Its Resubmitted New Drug Application For Brinavess
6/24/2019 7:01:54 AM Correvio Resubmits Brinavess NDA To FDA For Treatment Of Patients With Recent Onset Atrial Fibrillation
5/8/2019 8:04:46 AM Correvio Q1 Net Loss $9.0 Mln Or $0.23/Shr Vs Net Loss Of $8.5 Mln Or $0.24/Shr Last Year
  
 
>